A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
Summary of "A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma."
Abstract MSH6 (mutS homolog 6), one of the five key mismatch repair (MMR) genes, was found to play an important role in conferring resistance to alkylating agents - temozolomide (TMZ) in malignant glioma. This study aims to investigate whether genetic variations in MSH6 gene are associated with the survival outcomes in patients with malignant glioma. Each exon of the MSH6 gene was sequenced and single nucleotide polymorphism (SNP) analysis was performed using 74 tumor tissues from glioblastoma multiforme (GBM) patients. Among these patients, 54 patients received radiotherapy plus temozolomide (TMZ) treatment; 20 patients had radiotherapy only. The promoter methylation of O6-methylguanine methyltransferase (MGMT) was measured by MSP (methylation specific PCR). Literature mining and related data collection were done with NCBI and PubMed databases. Of the 74 GBM patients, 50% (n = 37) harbored MSH6 G268A polymorphism and no significant rates of other SNP or gene mutation across MSH6 exons were detected. The median OS was 15.6 months for who harbored the SNP and 12.6 months for SNP-negative patients (log-rank test: P = 0.324). The median OS for the MGMT promoter methylation group (n = 25) and non-methylation group (n = 29) of the 54 GBM patients treated with TMZ was 21.3 and 8.9 months respectively (P = 0.002). In conclusion, we identified a high frequency of MSH6 G268A polymorphism in MSH6 gene, which did not have a notable influence on survival for the malignant glioma patients with/without TMZ treatment.
Affiliation
1Dept. of Immunology, Harbin Medical University , 150081 Harbin , China.
Journal Details
This article was published in the following journal.
Name: The International journal of neuroscience
ISSN: 1563-5279
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/23057844
- DOI: http://dx.doi.org/10.3109/00207454.2012.738735
Medical and Biotech [MESH] Definitions
High-frequency Ventilation
Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation (HFPPV); HIGH-FREQUENCY JET VENTILATION; (HFJV); and high-frequency oscillation (HFO).
Terahertz Radiation
Non-ionizing electromagnetic energy in the frequency range of 100 gigahertz to 10 terahertz which spans from the mid-INFRARED RAYS frequency to the high-frequency edge of the MICROWAVES band.
Radio Waves
Electromagnetic waves with frequencies between about 3 kilohertz (very low frequency - VLF) and 300,000 megahertz (extremely high frequency - EHF). They are used in television and radio broadcasting, land and satellite communications systems, radionavigation, radiolocation, and DIATHERMY. The highest frequency radio waves are MICROWAVES.
Polymorphism, Single Nucleotide
A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.
High-intensity Focused Ultrasound Ablation
The use of focused, high-frequency sound waves to destroy tissue. It is sometimes used in conjunction with but is distinct from INTERVENTIONAL ULTRASONOGRAPHY.
PubMed Articles
Immunohistochemical staining for DNA mismatch repair proteins may be affected by various biological and technical factors. Staining variations that could potentially lead to erroneous interpretations...
MutS homolog 6 (MSH6) is the major mismatch contacting component of the MSH2-MSH6 heterodimeric complex (MutSalpha) that mediates DNA mismatch repair (MMR) of simple mispairs and small insertion-delet...
Analysis of Ggamma-158(C->T) polymorphism in hemoglobin E/beta-thalassemia major in Southern China.
ABSTRACT: BACKGROUND: The Ggamma-158(C->T) polymorphism plays an important role in the clinical variability of HbE/beta-thalassemia. There is little known about Ggamma-158(C->T) polymorphism in HbE/be...
Object Bcl-2 plays a key role in the downregulation of apoptosis and proliferation and leads to increased chemoresistance in glioblastoma multiforme (GBM). The authors investigated the role of a commo...
Glioblastoma survival in the United States before and during the temozolomide era.
The standard-of-care treatment for newly diagnosed glioblastoma changed in 2005, when radiation therapy plus temozolomide chemotherapy replaced radiation therapy alone. It is not yet clear how this ch...
Clinical Trials
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
The primary goal of this study is to determine if a stem cell transplant in patients with newly diagnosed high risk CNS tumors (glioblastoma multiforme [GBM], high grade astrocytoma, pineo...
Ketogenic Diet for Recurrent Glioblastoma
To determine whether a mild ketogenic diet can influences quality of life and survival of patients with recurrent glioblastoma
This is a study to see whether radiotherapy plus chemotherapy (Temozolomide) plus Dichloracetate (DCA) improves overall survival and offers better control of the disease in patients with n...
Investigational study to assess the overall response (OR) rate (CR + PR) of Imatinib mesylate and Hydroxyurea (Hydroxycarbamide) combination therapy on patients with recurrent glioblastoma...
The purpose of this research study is to try and identify a more effective treatment plan to improve survival rates for patients with a recurrent Glioblastoma Multiforme (GBM) brain tumor...
